221 related articles for article (PubMed ID: 22506624)
1. Patient perceptions associated with the 5% lidocaine medicated plaster in daily practice.
Überall MA; Müller-Schwefe GH
Curr Med Res Opin; 2012 Jun; 28(6):901-9. PubMed ID: 22506624
[TBL] [Abstract][Full Text] [Related]
2. Low-dose 7-day transdermal buprenorphine in daily clinical practice - perceptions of elderly patients with moderate non-malignant chronic pain.
Uberall MA; Müller-Schwefe GH
Curr Med Res Opin; 2012 Oct; 28(10):1585-95. PubMed ID: 22978772
[TBL] [Abstract][Full Text] [Related]
3. Topical pain management with the 5% lidocaine medicated plaster--a review.
Mick G; Correa-Illanes G
Curr Med Res Opin; 2012 Jun; 28(6):937-51. PubMed ID: 22551228
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
[TBL] [Abstract][Full Text] [Related]
5. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
[TBL] [Abstract][Full Text] [Related]
8. 5% lidocaine medicated plaster use in children with neuropathic pain from burn sequelae.
Orellana Silva M; Yañez V; Hidalgo G; Valenzuela F; Saavedra R
Pain Med; 2013 Mar; 14(3):422-9. PubMed ID: 23279572
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia.
Sabatowski R; Hans G; Tacken I; Kapanadze S; Buchheister B; Baron R
Curr Med Res Opin; 2012 Aug; 28(8):1337-46. PubMed ID: 22769236
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.
Hans G; Sabatowski R; Binder A; Boesl I; Rogers P; Baron R
Curr Med Res Opin; 2009 May; 25(5):1295-305. PubMed ID: 19366301
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
[TBL] [Abstract][Full Text] [Related]
12. [Experience with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
Fogliardi A; Brunori C
Minerva Med; 2013 Dec; 104(6):631-7. PubMed ID: 24316916
[TBL] [Abstract][Full Text] [Related]
13. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy.
Herrmann DN; Barbano RL; Hart-Gouleau S; Pennella-Vaughan J; Dworkin RH
Pain Med; 2005; 6(5):379-84. PubMed ID: 16266359
[TBL] [Abstract][Full Text] [Related]
14. [Topical pharmacologic approach with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
Provinciali L; Lattanzi S; Chiarlone R; Fogliardi A; Intelligente F; Irace C; Lanzilotta M; Palomba R; Storelli E; Zampi M
Minerva Med; 2014 Dec; 105(6):515-27. PubMed ID: 25392960
[TBL] [Abstract][Full Text] [Related]
15. [Localized neuropathic pain--5% lidocaine medicated patch as a first-line treatment and as add-on therapy: literature review and personal experience].
Casale R; Polati E; Schweiger V; Coluzzi F; Bhaskar A; Consalvo M
Minerva Med; 2014 Jun; 105(3):177-95. PubMed ID: 24988084
[TBL] [Abstract][Full Text] [Related]
16. Localized peripheral neuropathic pain: topical treatment with lidocaine 700 mg medicated plaster in routine clinical practice.
Überall MA; Bösl I; Hollanders E; Sabatschus I; Eerdekens M
Pain Manag; 2022 May; 12(4):521-533. PubMed ID: 35001660
[TBL] [Abstract][Full Text] [Related]
17. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
Binder A; Bruxelle J; Rogers P; Hans G; Bösl I; Baron R
Clin Drug Investig; 2009; 29(6):393-408. PubMed ID: 19432499
[TBL] [Abstract][Full Text] [Related]
18. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study.
Rehm S; Binder A; Baron R
Curr Med Res Opin; 2010 Jul; 26(7):1607-19. PubMed ID: 20429825
[TBL] [Abstract][Full Text] [Related]
19. Lidocaine 700 mg medicated plaster for postherpetic neuralgia: real-world data from the German Pain e-Registry.
Überall MA; Eerdekens M; Hollanders E; Bösl I; Sabatschus I
Pain Manag; 2022 Mar; 12(2):195-209. PubMed ID: 34372662
[TBL] [Abstract][Full Text] [Related]
20. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.
Ho KY; Huh BK; White WD; Yeh CC; Miller EJ
Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
